BVS
Bioventus Inc.
Key Financials
Net Income
$22.7M
↑ 167.8%
Gross Profit
$388.2M
↓ 0.0%
Revenue
$568.1M
↓ 0.9%
EPS (Diluted)
$0.33
↑ 163.5%
Operating Income
$54.0M
↑ 550.6%
Total Assets
$683.6M
↓ 6.1%
Shareholders' Equity
$184.1M
↑ 24.4%
Total Liabilities
$455.1M
↓ 16.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/5/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| SCHEDULE 13G | 7/27/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BVS |
| Company Name | Bioventus Inc. |
| CIK | 1665988 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (919) 474-6700 |